On November 20, 2024, Massachusetts-based GI Windows Surgical, a clinical-stage medical device company dedicated to developing the first fundamental breakthrough in anastomoses technology, announced the completion of a $37 million Series B financing round led by Orlando Health Ventures and joined by Rex Health Ventures with participation from existing investors including Johnson & Johnson Innovation–JJDC, JCInvestco, Fred Moll, MD, and an additional strategic investor. Wilson Sonsini Goodrich & Rosati advised GI Windows Surgical on the transaction.

The additional capital will support the ongoing clinical development of the company's proprietary Flexagon magnetic anastomosis technology.

The Wilson Sonsini team that advised GI Windows Surgical on the transaction includes Mark Solakian, Priyanka Nawathe, Rozman Lynch, Sean Donohue, Daniel Jordan, and Jason Schoenberg.

For more information, please see GI Windows Surgical's news release. Additional coverage can be found on MassDevice.